BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11450187)

  • 1. [Early detection of schizophrenic psychoses].
    Lauber C; Rössler W
    Praxis (Bern 1994); 2001 May; 90(22):987-92. PubMed ID: 11450187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Schizophrenics in the doctor's office. Diagnostic and therapeutic aspects].
    Bottlender R; Möller HJ
    MMW Fortschr Med; 2004 May; 146 Spec No 2():19-23. PubMed ID: 15376697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
    Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
    Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early detection and treatment of schizophrenia].
    Hasan A; Falkai P; Wobrock T
    MMW Fortschr Med; 2010 Mar; 152(9):53-5. PubMed ID: 20384099
    [No Abstract]   [Full Text] [Related]  

  • 5. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to prescribe an APAP?].
    Dassa D; Lacambre M; Vacheron MN
    Encephale; 2009 Jan; Suppl 3():S109-13. PubMed ID: 19268179
    [No Abstract]   [Full Text] [Related]  

  • 6. Prodromal symptoms and prevention of relapse in schizophrenia.
    Herz M
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):22-5. PubMed ID: 2865253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dilemma of early drug intervention in prepsychotic illnesses of adolescence].
    Branik E; Meng H
    Prax Kinderpsychol Kinderpsychiatr; 2003 Dec; 52(10):751-65. PubMed ID: 14699785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prodromal symptoms of schizophrenia].
    Elkhazen C; Chauchot F; Canceil O; Krebs MO; Baylé FJ
    Encephale; 2003; 29(6):469-77. PubMed ID: 15029081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Noncompliance--a typical problem in psychiatric patients. Individual, social and illness-specific factors].
    Hartung HD
    Fortschr Med; 1998 Jan; 116(3):28-30. PubMed ID: 9522542
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of relapse in schizophrenia is discontinued too soon. Many colleagues make this mistake!].
    Seemann U; Kissling W
    MMW Fortschr Med; 2000 Feb; 142(5):34-8. PubMed ID: 10715937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
    Naber D; Lambert M; Karow A
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
    Buis C; Gourion D; Vaiva G
    Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
    Altamura AC; Bobo WV; Meltzer HY
    Int Clin Psychopharmacol; 2007 Sep; 22(5):249-67. PubMed ID: 17690594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Longterm treatment of schizophrenia].
    Pajonk VF
    MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is there a primary prevention of schizophrenic psychiasis?].
    Klosterkötter J; Schultze-Lutter F
    Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S104-12. PubMed ID: 11533860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z; Britvić D; Vuković O; Ille T
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of untreated psychosis and it's effect on the functional outcome in schizophrenia - preliminary results.
    Sarotar BN; Pesek MB; Agius M; Pregelj P; Kocmur M
    Psychiatr Danub; 2008 Jun; 20(2):179-83. PubMed ID: 18587288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.
    Svestka J; Bitter I
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():95-116. PubMed ID: 17262005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.